|
|
(1) Complementary medicine pharmacist?
In this first article in a series discussing different aspects
of complementary medicine, Edzard Ernst looks at pharmacists’ current
attitudes
(PDF
110K)
Pharmaceutical Journal 2004;273:197-198 (7 August 2004)
|
|
(2) Is complementary medicine plausible?
In the second article in a series on complementary medicine, Edzard Ernst asks
if it is all just too implausible to be taken seriously
(PDF 45K)
Pharmaceutical Journal 2004;273:323 (4 September 2004)
|
|
(3) Hunches in complementary medicine
In the third article in our series on complementary medicine, Edzard Ernst asks
if these treatments should be available to all
(PDF 45K)
Pharmaceutical Journal 2004;273:477 (2 October 2004)
|
|
(4) Should we dismiss complementary medicine if evidence tells us to?
In the fourth article on complementary medicine, Edzard Ernst looks at the significance of negative evidence to consumers and pharmacists
(PDF 60K)
Pharmaceutical Journal 2004;273:722 (13 November 2004)
|
|
(5) Should we use “powerful placebos”?
In this fifth article on complementary medicine, Edzard Ernst debates the value
of the placebo effect
(PDF 45K)
Pharmaceutical Journal 2004;273:795 (27 November 2004)
|
|
(6) Media and complementary medicines
In the sixth article in a series on complementary medicine, Edzard Ernst questions the affect the media has on the reputation of these treatments
(PDF 70K)
Pharmaceutical Journal 2005;274:21 (1/8 January 2005)
|
|
(7) Beware the danger of applying double standards to complementary medicine
In this seventh article in a series on complementary medicine, Edzard Ernst tells
us why we need to apply the same level of objectivity to complementary medicine
as we do to conventional medicine
(PDF 90K)
Pharmaceutical Journal 2005;274:153 (5 February 2005)
|
|
(8) Complementary medicine in Germany
In this eighth article in a series on complementary medicine, Edzard Ernst compares
the German attitude with the approach in the UK
(PDF 110K)
Pharmaceutical Journal 2005;274:339 (19 March 2005)
|
|
(9) Complementary treatments on the NHS
In this ninth article in a series on complementary medicine, Edzard Ernst tells us why the Government’s “proposal” to integrate complementary treatments with the NHS is merely an election gimmick
(PDF 60K)
Pharmaceutical Journal 2005;274:426 (9 April 2005)
|
|
(10) Why looking at complementary medicine receives so little funding
In the 10th article in a series on complementary medicine, Edzard Ernst suggests
ways to remedy the paucity of research funding in this field
(PDF 60K)
Pharmaceutical Journal 2005;274:557 (7 May 2005)
|
|
(11) Medicines guilty until proven innocent
In the 11th article in a series on complementary medicine, Edzard Ernst says
that even though complementary medicines have been used for hundreds of years,
good evidence of safety and efficacy are required
(PDF 85K)
Pharmaceutical Journal 2005;274:679 (4 June 2005)
|
|
(12) Why alternative medicines are used
In the 12th article in a series on complementary medicine, Edzard Ernst looks
at the reasons that lead consumers to try alternative medicines
(PDF 90K)
Pharmaceutical Journal 2005;275:55 (9 July 2005)
|
|
(13) Contamination of herbal medicines
In the 13th article in a series on complementary medicine, Edzard Ernst points
to several cases of contamination of herbal medicines and looks at advice to
give to users
(PDF 190K)
Pharmaceutical Journal 2005;275:167-168 (6 August 2005)
|
|
(14) Recommended information sources
In this 14th article on complementary medicine, Edzard Ernst discusses the need
for reliable sources of information and suggests useful texts for practising
pharmacists who need to be able to find answers quickly
(PDF 50K)
Pharmaceutical Journal 2005;275:348 (17 September 2005)
|
|
(15) Alternative cancer
cures are a myth
In the 15th article in a series on complementary medicine, Edzard Ernst explains
why there will never be an alternative cure for cancer
(PDF 80K)
Pharmaceutical Journal 2005;275:447 (8 October 2005)
|
|
(16) Complementary medicine: clinical trials
In the 16th article of a series on complementary medicine, Edzard Ernst looks
at the arguments for and against performing clinical trials
(PDF 80K)
Pharmaceutical Journal 2005;275:612 (12 November 2005)
|
|
(17) The future of complementary medicine
In this final article in a series on complementary medicine, Edzard Ernst says
he is still optimistic for the future
(PDF 160K)
Pharmaceutical Journal 2005;275:699-700 (3 December 2005)
|
Acrobat
Reader